CY1122360T1 - Μεθοδος για τη διαγνωση της νοσου niemann-pick - Google Patents

Μεθοδος για τη διαγνωση της νοσου niemann-pick

Info

Publication number
CY1122360T1
CY1122360T1 CY20191101122T CY191101122T CY1122360T1 CY 1122360 T1 CY1122360 T1 CY 1122360T1 CY 20191101122 T CY20191101122 T CY 20191101122T CY 191101122 T CY191101122 T CY 191101122T CY 1122360 T1 CY1122360 T1 CY 1122360T1
Authority
CY
Cyprus
Prior art keywords
niemann
diagnosis
pick disease
subject
pick
Prior art date
Application number
CY20191101122T
Other languages
Greek (el)
English (en)
Inventor
Arndt Rolfs
Hermann Mascher
Original Assignee
Centogene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centogene Ag filed Critical Centogene Ag
Publication of CY1122360T1 publication Critical patent/CY1122360T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CY20191101122T 2011-11-15 2019-10-30 Μεθοδος για τη διαγνωση της νοσου niemann-pick CY1122360T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11009062 2011-11-15
PCT/EP2012/004756 WO2013072060A2 (en) 2011-11-15 2012-11-15 Method for the diagnosis of niemann-pick disease
EP12790426.6A EP2780716B1 (en) 2011-11-15 2012-11-15 Method for the diagnosis of niemann-pick disease

Publications (1)

Publication Number Publication Date
CY1122360T1 true CY1122360T1 (el) 2021-01-27

Family

ID=47221301

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191101122T CY1122360T1 (el) 2011-11-15 2019-10-30 Μεθοδος για τη διαγνωση της νοσου niemann-pick

Country Status (11)

Country Link
US (4) US9910033B2 (enExample)
EP (1) EP2780716B1 (enExample)
JP (2) JP6243846B2 (enExample)
AU (3) AU2012339149A1 (enExample)
BR (1) BR112014009223B1 (enExample)
CA (1) CA2854668A1 (enExample)
CY (1) CY1122360T1 (enExample)
DK (1) DK2780716T3 (enExample)
IL (1) IL231982B (enExample)
MX (2) MX359328B (enExample)
WO (1) WO2013072060A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153083A1 (en) 2013-03-14 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
MX370570B (es) 2013-06-07 2019-12-17 Genzyme Corp Marcador para trastornos de la esfingomielinasa acida y sus usos.
CA3002526A1 (en) 2014-10-28 2016-05-06 Washington University Bile acid biomarkers for niemann-pick diseases, methods and uses therefor
US20180348239A1 (en) * 2014-11-19 2018-12-06 Centogene Ag Method for the Diagnosis of Niemann-Pick Disease Using a Biomarker
US10656059B2 (en) 2018-03-07 2020-05-19 Alcala Pharmaceutical, Inc. Method for qualitative and quantitative multiplexing of drug analytes from biological samples
US20190369113A1 (en) * 2018-06-01 2019-12-05 Laboratory Corporation Of America Holdings Simplified Biosample Processing for LC-MS/MS
CN111289647A (zh) * 2020-03-09 2020-06-16 广州市妇女儿童医疗中心(广州市妇幼保健院、广州市儿童医院、广州市妇婴医院、广州市妇幼保健计划生育服务中心) 葡糖鞘氨醇的检测方法
WO2024026390A2 (en) * 2022-07-28 2024-02-01 Wylder Nation Foundation Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4498918B2 (ja) * 2002-04-30 2010-07-07 生化学工業株式会社 リソソーム病の検出方法
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
CA2773133A1 (en) 2009-08-28 2011-03-03 Edward H. Schuchman Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

Also Published As

Publication number Publication date
US20180088107A1 (en) 2018-03-29
MX381530B (es) 2025-03-12
MX2014005923A (es) 2014-09-08
DK2780716T3 (da) 2019-10-14
US20220187283A1 (en) 2022-06-16
JP6711807B2 (ja) 2020-06-17
US20140309140A1 (en) 2014-10-16
WO2013072060A8 (en) 2014-07-17
AU2021204429A1 (en) 2021-07-29
US11841362B2 (en) 2023-12-12
US11231412B2 (en) 2022-01-25
IL231982A0 (en) 2014-05-28
MX359328B (es) 2018-09-25
BR112014009223A2 (pt) 2017-06-13
BR112014009223A8 (pt) 2017-06-20
AU2012339149A1 (en) 2014-04-24
CA2854668A1 (en) 2013-05-23
US10422789B2 (en) 2019-09-24
JP2018054620A (ja) 2018-04-05
US20200072819A1 (en) 2020-03-05
AU2018229451B2 (en) 2021-04-01
US9910033B2 (en) 2018-03-06
EP2780716A2 (en) 2014-09-24
IL231982B (en) 2020-01-30
WO2013072060A2 (en) 2013-05-23
AU2021204429B2 (en) 2024-01-25
JP6243846B2 (ja) 2017-12-06
AU2018229451A1 (en) 2018-10-04
AU2012339149A8 (en) 2014-05-08
EP2780716B1 (en) 2019-07-31
WO2013072060A3 (en) 2013-07-25
JP2014533367A (ja) 2014-12-11
BR112014009223B1 (pt) 2021-04-06

Similar Documents

Publication Publication Date Title
EA201590027A1 (ru) Способы детекции заболеваний или состояний
BR112014018831A2 (pt) método para otimizar sensibilidade e/ou seletividade de um sensor para um ou mais analitos, método para formar um sensor para um ou mais analitos, kit para a detecção de um ou mais analitos, método de identificação de um aptâmero, composição de matéria e aptâmeros.
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
DK3356556T3 (da) Fremgangsmåde til diagnose af en sygdom ved detektion af circRNA i kropsvæsker
EP3636776C0 (en) METHODS FOR ANALYSIS OF NUCLEIC SEQUENCE INFORMATION USING GC BIAS, POSSIBLY FOR THE DETECTION OF FETAL NUCLEIC ACID ABNORMALITIES
IL231626A0 (en) Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
WO2013084002A3 (en) Method for detecting nucleosome adducts
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
WO2013096817A3 (en) A testing cartridge comprising electrochemical sensors and an optical microarray
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
EP2676122A4 (en) AMPEROMETRIC SENSOR SYSTEM
MX359328B (es) Metodo para el diagnostico de enfermedad de niemann-pick.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EA201490533A1 (ru) Способы и композиции для определения статуса в отношении курения
EP2516681A4 (en) COMPOSITIONS AND METHOD FOR DETECTING SMALL RNAS
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
EP2495569A4 (en) METHOD FOR DETERMINING SENSITIVITY TO ANTICREME AGENT
IN2012DN01910A (enExample)
CL2014000103A1 (es) Metodo para determinar el pronostico de una enfermedad o la prognosis de un paciente diagnosticado con mieloma multiple.
CY1121282T1 (el) Μεθοδος ανιχνευσης της μολυνσης απο η.pylori
BR112015014232A2 (pt) lesão renal aguda
EP2592996A4 (en) METHOD FOR DIAGNOSING WALL DIFFUSER DISORDERS
CY1121790T1 (el) Μεθοδος για τη διαγνωση της νοσου niemann-pick
WO2011130647A3 (en) Compositions and methods for characterizing a myopathy